Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Todd Hill v. Macrogenics, Inc. et al
Case Number:
8:19-cv-02713
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
-
September 30, 2021
MacroGenics Escapes Investor Stock Drop Suit
An investor suit against biopharmaceutical company MacroGenics was dismissed on Wednesday by a Maryland federal judge who said the plaintiffs failed to show enough facts to support their claims of fraud and scienter.
-
September 16, 2019
Investors Say Cancer Drug Co. Hyped Up Trial Results
Investors in a clinical-stage biopharmaceutical company have filed a proposed class action in Maryland federal court, accusing the drugmaker of falsely overstating the success of a breast cancer drug.